Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
GOAL 3 is a social enterprise founded in 2019 and headquartered in the Netherlands. Its core product, IMPALA, is designed for low-resource healthcare facilities, especially pediatric and neonatal wards. Rather than a traditional pure SaaS product, it is a clinical support system combining monitoring hardware, platform software, and ongoing services. Its goal is to help healthcare workers detect patient deterioration earlier, prioritize care, and reduce the nursing workload.
IMPALA has three layers. IMPALA Monitor is a continuous multi-parameter vital signs monitoring device, with an emphasis on durability, ease of use, and suitability for resource-limited environments. IMPALA Platform provides a central patient overview, a clinical support app, and data dashboards, allowing staff to view patient status, history, event markers, unattended patients, and aggregated ward data. IMPALA Care covers implementation, training, e-learning, WhatsApp communities, remote troubleshooting, quarterly system checks, spare parts, and consumables support. The official website also states that the system combines simplified electronic patient records with visualized clinical data.
The official website does not publish standard plans, pricing, or payment methods. It only notes that hybrid business models can improve accessibility for hospital adoption, and interested organizations need to make an inquiry. For third-party integrations, the site says its digital infrastructure makes it easier to connect with EMRs, telemedicine, decision-support applications, and algorithms, but it does not provide specific APIs, developer documentation, or an integration list. The deployment model is also not clearly labeled as cloud-based or self-hosted. What can be confirmed is that it includes monitoring devices, communication tools, tablets, servers, and software, and supports remote system monitoring and troubleshooting.
Its strengths lie in its highly focused approach to low-resource healthcare settings, its integrated hardware-software design around clinical workflows, and the inclusion of training, maintenance, and local service as part of the product system. The official website discloses implementation and validation cases in Malawi, Tanzania, Rwanda, and other locations. The main drawbacks are the lack of transparency around commercialization: there is little information on pricing, plans, compliance, security, permissions, open APIs, and other materials commonly needed for enterprise procurement. For Chinese hospitals or enterprise customers, there is also no visible information about local certification, after-sales support, language support, or payment adaptation.
IMPALA is better suited to hospitals in low-resource regions such as Africa, government public-health programs, and healthcare capacity-building projects supported by NGOs and foundations, rather than general enterprise SaaS users. Access from China cannot be determined from the official website, so it is marked as unknown. If Chinese medical institutions are looking for alternatives, they may consider patient monitoring and hospital information solutions from Mindray, Philips, GE HealthCare, and similar providers.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on goal3.org official site.
goal3.org is an Netherlands Health provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach goal3.org directly.